Cambrex to Exhibit at Informex USA 2014

East Rutherford, NJ – Cambrex Corporation (NYSE: CBM, “Cambrex”) will be exhibiting its small molecule API products and services designed to accelerate the commercialization of finished drug products at Informex USA 2014, January 22-24 in Miami Beach, Florida. In addition, Cambrex will be presenting at the Informex Exhibitor Showcase on January 21.

Cambrex will be showcasing its custom development and manufacturing capabilities including analytical development, process validation and finished dosage form manufacture with a portfolio of offerings that include controlled substances, high potency APIs, high energy chemistries, chiral compounds, drug delivery and biotransformation technologies. Cambrex manufactures over 70 generic and branded APIs, as well as advanced pharmaceutical intermediates.

During the Informex Exhibitor Showcase, Joe Nettleton, VP of Operations at Cambrex Charles City, will discuss Cambrex’s custom development and manufacturing capabilities. With a strong focus on quality, Cambrex has been reliably supplying custom API development and manufacturing services to the pharmaceutical industry for more than 30 years.

Cambrex is exhibiting at Booth 539 in the Miami Beach Convention Center during Informex USA.

Cambrex Icon
Posted by Cambrex